A citation-based method for searching scientific literature

Julia Krammer, Katja Pinker-Domenig, Mark E Robson, Mithat Gönen, Blanca Bernard-Davila, Elizabeth A Morris, Debra A Mangino, Maxine S Jochelson. Breast Cancer Res Treat 2017
Times Cited: 49







List of co-cited articles
284 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Triple-modality screening trial for familial breast cancer underlines the importance of magnetic resonance imaging and questions the role of mammography and ultrasound regardless of patient mutation status, age, and breast density.
Christopher C Riedl, Nikolaus Luft, Clemens Bernhart, Michael Weber, Maria Bernathova, Muy-Kheng M Tea, Margaretha Rudas, Christian F Singer, Thomas H Helbich. J Clin Oncol 2015
143
28

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition.
Mieke Kriege, Cecile T M Brekelmans, Carla Boetes, Peter E Besnard, Harmine M Zonderland, Inge Marie Obdeijn, Radu A Manoliu, Theo Kok, Hans Peterse, Madeleine M A Tilanus-Linthorst,[...]. N Engl J Med 2004
24

Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA).
Nasim Mavaddat, Daniel Barrowdale, Irene L Andrulis, Susan M Domchek, Diana Eccles, Heli Nevanlinna, Susan J Ramus, Amanda Spurdle, Mark Robson, Mark Sherman,[...]. Cancer Epidemiol Biomarkers Prev 2012
355
20

Surveillance of BRCA1 and BRCA2 mutation carriers with magnetic resonance imaging, ultrasound, mammography, and clinical breast examination.
Ellen Warner, Donald B Plewes, Kimberley A Hill, Petrina A Causer, Judit T Zubovits, Roberta A Jong, Margaret R Cutrara, Gerrit DeBoer, Martin J Yaffe, Sandra J Messner,[...]. JAMA 2004
773
20

Contribution of mammography to MRI screening in BRCA mutation carriers by BRCA status and age: individual patient data meta-analysis.
Xuan-Anh Phi, Sepideh Saadatmand, Geertruida H De Bock, Ellen Warner, Francesco Sardanelli, Martin O Leach, Christopher C Riedl, Isabelle Trop, Maartje J Hooning, Rodica Mandel,[...]. Br J Cancer 2016
48
20

Prospective multicenter cohort study to refine management recommendations for women at elevated familial risk of breast cancer: the EVA trial.
Christiane Kuhl, Stefanie Weigel, Simone Schrading, Birke Arand, Heribert Bieling, Roy König, Bernd Tombach, Claudia Leutner, Andrea Rieber-Brambs, Dennis Nordhoff,[...]. J Clin Oncol 2010
275
18

American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography.
Debbie Saslow, Carla Boetes, Wylie Burke, Steven Harms, Martin O Leach, Constance D Lehman, Elizabeth Morris, Etta Pisano, Mitchell Schnall, Stephen Sener,[...]. CA Cancer J Clin 2007
18

Surveillance of Women with the BRCA1 or BRCA2 Mutation by Using Biannual Automated Breast US, MR Imaging, and Mammography.
Jan C M van Zelst, Roel D M Mus, Gwendolyn Woldringh, Matthieu J C M Rutten, Peter Bult, Suzan Vreemann, Mathijn de Jong, Nico Karssemeijer, Nicoline Hoogerbrugge, Ritse M Mann. Radiology 2017
43
20

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers.
Karoline B Kuchenbaecker, John L Hopper, Daniel R Barnes, Kelly-Anne Phillips, Thea M Mooij, Marie-José Roos-Blom, Sarah Jervis, Flora E van Leeuwen, Roger L Milne, Nadine Andrieu,[...]. JAMA 2017
18

Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer.
Deann P Atchley, Constance T Albarracin, Adriana Lopez, Vicente Valero, Christopher I Amos, Ana Maria Gonzalez-Angulo, Gabriel N Hortobagyi, Banu K Arun. J Clin Oncol 2008
366
16

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
16

Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer.
Christiane K Kuhl, Simone Schrading, Claudia C Leutner, Nuschin Morakkabati-Spitz, Eva Wardelmann, Rolf Fimmers, Walther Kuhn, Hans H Schild. J Clin Oncol 2005
656
16

Should we screen BRCA1 mutation carriers only with MRI? A multicenter study.
Inge-Marie Obdeijn, Gonneke A O Winter-Warnars, Ritse M Mann, Maartje J Hooning, M G Myriam Hunink, Madeleine M A Tilanus-Linthorst. Breast Cancer Res Treat 2014
39
20

Long-term results of screening with magnetic resonance imaging in women with BRCA mutations.
K Passaperuma, E Warner, P A Causer, K A Hill, S Messner, J W Wong, R A Jong, F C Wright, M J Yaffe, E A Ramsay,[...]. Br J Cancer 2012
114
14

Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR.
Debra L Monticciolo, Mary S Newell, Linda Moy, Bethany Niell, Barbara Monsees, Edward A Sickles. J Am Coll Radiol 2018
237
14

Breast Cancers Detected at Screening MR Imaging and Mammography in Patients at High Risk: Method of Detection Reflects Tumor Histopathologic Results.
Janice S Sung, Sarah Stamler, Jennifer Brooks, Jennifer Kaplan, Tammy Huang, D David Dershaw, Carol H Lee, Elizabeth A Morris, Christopher E Comstock. Radiology 2016
67
14

Breast-cancer risk in families with mutations in PALB2.
Antonis C Antoniou, Silvia Casadei, Tuomas Heikkinen, Daniel Barrowdale, Katri Pylkäs, Jonathan Roberts, Andrew Lee, Deepak Subramanian, Kim De Leeneer, Florentia Fostira,[...]. N Engl J Med 2014
510
14

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
12

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.
Sunil R Lakhani, Marc J Van De Vijver, Jocelyne Jacquemier, Thomas J Anderson, Peter P Osin, Lesley McGuffog, Douglas F Easton. J Clin Oncol 2002
594
12

Multicenter surveillance of women at high genetic breast cancer risk using mammography, ultrasonography, and contrast-enhanced magnetic resonance imaging (the high breast cancer risk italian 1 study): final results.
Francesco Sardanelli, Franca Podo, Filippo Santoro, Siranoush Manoukian, Silvana Bergonzi, Giovanna Trecate, Daniele Vergnaghi, Massimo Federico, Laura Cortesi, Stefano Corcione,[...]. Invest Radiol 2011
197
12

Influence of Risk Category and Screening Round on the Performance of an MR Imaging and Mammography Screening Program in Carriers of the BRCA Mutation and Other Women at Increased Risk.
Suzan Vreemann, Albert Gubern-Mérida, Margrethe S Schlooz-Vries, Peter Bult, Carla H van Gils, Nicoline Hoogerbrugge, Nico Karssemeijer, Ritse M Mann. Radiology 2018
27
22

Supplemental Breast MR Imaging Screening of Women with Average Risk of Breast Cancer.
Christiane K Kuhl, Kevin Strobel, Heribert Bieling, Claudia Leutner, Hans H Schild, Simone Schrading. Radiology 2017
143
12

Breast MRI: EUSOBI recommendations for women's information.
Ritse M Mann, Corinne Balleyguier, Pascal A Baltzer, Ulrich Bick, Catherine Colin, Eleanor Cornford, Andrew Evans, Eva Fallenberg, Gabor Forrai, Michael H Fuchsjäger,[...]. Eur Radiol 2015
193
12

Abbreviated breast magnetic resonance imaging (MRI): first postcontrast subtracted images and maximum-intensity projection-a novel approach to breast cancer screening with MRI.
Christiane K Kuhl, Simone Schrading, Kevin Strobel, Hans H Schild, Ralf-Dieter Hilgers, Heribert B Bieling. J Clin Oncol 2014
302
12

Mammographic, US, and MR imaging phenotypes of familial breast cancer.
Simone Schrading, Christiane K Kuhl. Radiology 2008
124
12

Association of BRCA Mutation Types, Imaging Features, and Pathologic Findings in Patients With Breast Cancer With BRCA1 and BRCA2 Mutations.
Su Min Ha, Eun Young Chae, Joo Hee Cha, Hak Hee Kim, Hee Jung Shin, Woo Jung Choi. AJR Am J Roentgenol 2017
30
20


Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS).
M O Leach, C R M Boggis, A K Dixon, D F Easton, R A Eeles, D G R Evans, F J Gilbert, I Griebsch, R J C Hoff, P Kessar,[...]. Lancet 2005
706
12

The added value of mammography in different age-groups of women with and without BRCA mutation screened with breast MRI.
Suzan Vreemann, Jan C M van Zelst, Margrethe Schlooz-Vries, Peter Bult, Nicoline Hoogerbrugge, Nico Karssemeijer, Albert Gubern-Mérida, Ritse M Mann. Breast Cancer Res 2018
18
33

Differences in natural history between breast cancers in BRCA1 and BRCA2 mutation carriers and effects of MRI screening-MRISC, MARIBS, and Canadian studies combined.
Eveline A M Heijnsdijk, Ellen Warner, Fiona J Gilbert, Madeleine M A Tilanus-Linthorst, Gareth Evans, Petrina A Causer, Rosalind A Eeles, Reinie Kaas, Gerrit Draisma, Elizabeth A Ramsay,[...]. Cancer Epidemiol Biomarkers Prev 2012
54
12

BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study.
Adriana J Rijnsburger, Inge-Marie Obdeijn, Reinoutje Kaas, Madeleine M A Tilanus-Linthorst, Carla Boetes, Claudette E Loo, Martin N J M Wasser, Elisabeth Bergers, Theo Kok, Sara H Muller,[...]. J Clin Oncol 2010
116
12


Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.
Nasim Mavaddat, Susan Peock, Debra Frost, Steve Ellis, Radka Platte, Elena Fineberg, D Gareth Evans, Louise Izatt, Rosalind A Eeles, Julian Adlard,[...]. J Natl Cancer Inst 2013
528
10

Meta-analysis of BRCA1 and BRCA2 penetrance.
Sining Chen, Giovanni Parmigiani. J Clin Oncol 2007
10

Breast MRI: guidelines from the European Society of Breast Imaging.
R M Mann, C K Kuhl, K Kinkel, C Boetes. Eur Radiol 2008
418
10

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.
Sue Richards, Nazneen Aziz, Sherri Bale, David Bick, Soma Das, Julie Gastier-Foster, Wayne W Grody, Madhuri Hegde, Elaine Lyon, Elaine Spector,[...]. Genet Med 2015
10

Intensive Surveillance with Biannual Dynamic Contrast-Enhanced Magnetic Resonance Imaging Downstages Breast Cancer in BRCA1 Mutation Carriers.
Rodrigo Santa Cruz Guindalini, Yonglan Zheng, Hiroyuki Abe, Kristen Whitaker, Toshio F Yoshimatsu, Tom Walsh, David Schacht, Kirti Kulkarni, Deepa Sheth, Marion S Verp,[...]. Clin Cancer Res 2019
27
18

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy.
Hannah Farmer, Nuala McCabe, Christopher J Lord, Andrew N J Tutt, Damian A Johnson, Tobias B Richardson, Manuela Santarosa, Krystyna J Dillon, Ian Hickson, Charlotte Knights,[...]. Nature 2005
8

Effect of BRCA germline mutations on breast cancer prognosis: A systematic review and meta-analysis.
Zora Baretta, Simone Mocellin, Elena Goldin, Olufunmilayo I Olopade, Dezheng Huo. Medicine (Baltimore) 2016
81
8

Magnetic resonance imaging of the breast: recommendations from the EUSOMA working group.
Francesco Sardanelli, Carla Boetes, Bettina Borisch, Thomas Decker, Massimo Federico, Fiona J Gilbert, Thomas Helbich, Sylvia H Heywang-Köbrunner, Werner A Kaiser, Michael J Kerin,[...]. Eur J Cancer 2010
537
8

Breast cancer detection using double reading of unenhanced MRI including T1-weighted, T2-weighted STIR, and diffusion-weighted imaging: a proof of concept study.
Rubina M Trimboli, Nicola Verardi, Francesco Cartia, Luca A Carbonaro, Francesco Sardanelli. AJR Am J Roentgenol 2014
56
8

Application of Abbreviated Protocol of Magnetic Resonance Imaging for Breast Cancer Screening in Dense Breast Tissue.
Shuang-Qing Chen, Min Huang, Yu-Ying Shen, Chen-Lu Liu, Chuan-Xiao Xu. Acad Radiol 2017
37
10

Mammographic screening in BRCA1 mutation carriers postponed until age 40: Evaluation of benefits, costs and radiation risks using models.
Inge-Marie Obdeijn, Eveline A M Heijnsdijk, M G Myriam Hunink, Madeleine M A Tilanus-Linthorst, Harry J de Koning. Eur J Cancer 2016
11
36

Cost-effectiveness of alternating magnetic resonance imaging and digital mammography screening in BRCA1 and BRCA2 gene mutation carriers.
Jessica E Cott Chubiz, Janie M Lee, Michael E Gilmore, Chung Y Kong, Kathryn P Lowry, Elkan F Halpern, Pamela M McMahon, Paula D Ryan, G Scott Gazelle. Cancer 2013
48
8

Breast cancer screening with imaging: recommendations from the Society of Breast Imaging and the ACR on the use of mammography, breast MRI, breast ultrasound, and other technologies for the detection of clinically occult breast cancer.
Carol H Lee, D David Dershaw, Daniel Kopans, Phil Evans, Barbara Monsees, Debra Monticciolo, R James Brenner, Lawrence Bassett, Wendie Berg, Stephen Feig,[...]. J Am Coll Radiol 2010
422
8

Annual screening strategies in BRCA1 and BRCA2 gene mutation carriers: a comparative effectiveness analysis.
Kathryn P Lowry, Janie M Lee, Chung Y Kong, Pamela M McMahon, Michael E Gilmore, Jessica E Cott Chubiz, Etta D Pisano, Constantine Gatsonis, Paula D Ryan, Elissa M Ozanne,[...]. Cancer 2012
60
8

Prospective study of breast cancer incidence in women with a BRCA1 or BRCA2 mutation under surveillance with and without magnetic resonance imaging.
Ellen Warner, Kimberley Hill, Petrina Causer, Donald Plewes, Roberta Jong, Martin Yaffe, William D Foulkes, Parviz Ghadirian, Henry Lynch, Fergus Couch,[...]. J Clin Oncol 2011
165
8

Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk.
Wendie A Berg, Zheng Zhang, Daniel Lehrer, Roberta A Jong, Etta D Pisano, Richard G Barr, Marcela Böhm-Vélez, Mary C Mahoney, W Phil Evans, Linda H Larsen,[...]. JAMA 2012
591
8

Sensitivity of MRI versus conventional screening in the diagnosis of BRCA-associated breast cancer in a national prospective series.
Anne I Hagen, Kjell Arne Kvistad, Lovise Maehle, Marit Muri Holmen, Hildegunn Aase, Bodil Styr, Anita Vabø, Jaran Apold, Per Skaane, Pål Møller. Breast 2007
118
8

Effectiveness of screening with annual magnetic resonance imaging and mammography: results of the initial screen from the ontario high risk breast screening program.
Anna M Chiarelli, Maegan V Prummel, Derek Muradali, Vicky Majpruz, Meaghan Horgan, June C Carroll, Andrea Eisen, Wendy S Meschino, Rene S Shumak, Ellen Warner,[...]. J Clin Oncol 2014
68
8


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.